Simplex Trading, LLC Kymera Therapeutics, Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$20.91 - $34.27 $76,237 - $124,948	3,646 Added 1321.01%	3,922 $85,000
Q2 2022 Aug 03, 2022	SELL	$14.13 - $42.55 $48,734 - $146,754	-3,449 Reduced 92.59%	276 $5,000
Q1 2022 May 02, 2022	BUY	$35.3 - $64.68 $131,316 - $240,609	3,720 Added 74400.0%	3,725 $157,000
Q4 2021 Feb 23, 2022	SELL	$49.91 - $65.56 $67,628 - $88,833	-1,355 Reduced 99.63%	5 $0
Q3 2021 Oct 28, 2021	BUY	$47.8 - $66.66 $48,660 - $67,859	1,018 Added 297.66%	1,360 $76,000
Q2 2021 Aug 12, 2021	BUY	$31.08 - $51.95 $10,629 - $17,766	342 New	342 $16,000

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.3B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.